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Clinical observations and epidemiologic studies suggest that the incidence of head and neck squamous cell
carcinoma (HNSCC) correlates with dental hygiene, implying a role for bacteria-induced inﬂammation in its
pathogenesis. Here we begin to explore the pilot hypothesis that speciﬁc microbial populations may contribute
to HNSCC pathogenesis via epigenetic modiﬁcations in inﬂammatory- and HNSCC-associated genes.
Microbiomic proﬁling by 16S rRNA sequencing of matched tumor and adjacent normal tissue specimens in
42 individuals with HNSCC demonstrate a signiﬁcant association of speciﬁc bacterial subpopulations with
HNSCC over normal tissue (P < 0.01). Furthermore, microbial populations can separate tumors by tobacco
status (P < 0.008), but not by alcohol status (P 5 0.41). If our subhypothesis regarding a mechanistic link
from microorganism to carcinogenesis via inﬂammation and consequent aberrant DNA methylation is correct,
then we should see hypermethylation of relevant genes associate with speciﬁc microbiomic proﬁles.
Methylation analysis in four genes (MDR1, IL8, RARB, TGFBR2) previously linked to HNSCC or inﬂammation
shows signiﬁcantly increased methylation in tumor samples compared with normal oral mucosa. Of these,
MDR1 promoter methylation associates with speciﬁc microbiomic proﬁles in tumor over normal mucosa.
Additionally, we report that MDR1 methylation correlates with regional nodal metastases in the context of
two speciﬁc bacterial subpopulations, Enterobacteriaceae and Tenericutes (P < 0.001 for each). These associa-
tions may lead to a different, and potentially more comprehensive, perspective on the pathogenesis of HNSCC,
and support further exploration of mechanistic linkage and, if so, novel therapeutic strategies such as
demethylating agents and probiotic adjuncts, particularly for patients with advanced or refractory disease.
INTRODUCTION
Head and neck squamous cell carcinoma (HNSCC) is the sixth
most common cancer worldwide, accounting for more than 500
000 new cases each year. This malignancy affects the squamous
cells lining the oral cavity, hypopharynx, pharynx and larynx. Al-
though the main cause for this cancer stems from exposure to
tobacco and alcohol, infection with high-risk human papilloma-
virus (HPV) subtypes and Epstein-Barr virus, as well as oral
hygiene, are important etiologic factors in subsets of the cases
(1). Patients often present with metastatic nodal disease, and 25%
of cases will develop second malignancies 5 years post-diagnosis.
Unfortunately, because patients do not manifest the disease until
advanced stages, clinical outcome is poor, with ,50% surviving
5years.Despitegrowingresearcheffortsinthisﬁeldandincreasing
knowledge of the impact of HPV, there has been non-exponential
improvementinthetreatmentandnoimprovementinearlydiagno-
sis for this disease.
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Advance Access published on December 15, 2011The microbiome inthe gastrointestinal tract is acomplexand
dynamicsysteminteractingwiththehostorganism(2).Thehost
organism beneﬁts from this symbiotic relationship by harnes-
singthemicrobiome’strophicservicesinitsenergymetabolism
(3). The native microbiome of mammals can also play a role in
themetabolismofdrugsandfoods,alteringtheiravailabilityand
useforthehost(4).Regardlessofthefunction andbeneﬁtofthe
microbiome to its host, some bacterial populations can be the
source of pathogenic infections or carcinogenesis (5). Helico-
bacter pylori (H. pylori) in the stomach is a well-known
example, which can cause gastritis, gastric ulcers and, in some
cases, gastric cancer (6).
When H. pylori was linked with gastric cancer and its eradi-
cation was associated with regression, a paradigm-shifting
model of carcinogenesis was created. The overreaction of
host cells to pathogenic intestinal bacteria can cause chronic
inﬂammation and the release of stimulatory and mutagenic
cytokines, which results in altered gene expression. Further-
more, chronic inﬂammation has the potential to induce
several mediators, such as nuclear factor-kappaB, that can
lend to carcinogenesis through enhanced cell growth advan-
tage and apoptotic resistance (7). There is substantial evidence
for a signiﬁcant association between chronic inﬂammation and
malignant transformation (8). For example, inﬂammatory
responses can cause both somatic genetic and epigenetic
alterations, which ultimately disrupts the cellular homeostasis
necessary in preventing malignant transformation (7,9).
The inﬂammation associated with bacteria has also been
demonstrated to lead to the upregulation of an enzyme that
causes DNA mutations in the genome (10). These types of
inﬂammation-induced DNA damage can cause aberrant de
novo DNA methylation during carcinogenesis (11). Because
the hypermethylation events discussed in this context are
observed in response to chronic inﬂammation, it is feasible
thattheycouldserveasearlycancerindicatorsandwouldthere-
foreactaseffectivetumormarkersfordiagnosticscreening(11).
Decreased expression of multidrug resistance gene 1 (MDR1)
and bacteria-triggered inﬂammation has both been linked to in-
ﬂammatory bowel disease, ulcerative colitis and gastric cancer
(12,13).Interestingly, MDR1 has been implicated aspotentially
relevant in the context of tobacco-related diseases (such as
HNSCC). This gene is highly expressed in bronchial epithelial
cells in order to handle toxic substances crossing the cellular
membrane (14). Therefore, silencing of MDR1 results in
chronic obstructivepulmonarydiseasefromdecreased detoxiﬁ-
cation of cigarette smoke and/or other toxic inhalants (15).
To explore the relation between inﬂammation, somatic pro-
moter methylation and oral microbiota, we chose in this paper
to focus on MDR1 and three other genes related to HNSCC or
oral inﬂammation: IL8, RARB and TGFBRII. IL8 codes for an
inﬂammatory cytokine with differential methylation in epithe-
lial oral cells of individuals with and without chronic peri-
odontitis (16). In multiple studies, RARB shows aberrant
promoter methylation in HNSCC (17). Downregulation of
TGFBR2 and the loss of the chromosome on which it
resides occur frequently in HNSCC tumors (1,16,18,19).
In this study, we aim to uncover a potential association
between the oral microbiome and HNSCC pathogenesis.
While the microbiomes of normal human oral mucosa, skin
and gut are being explored (20), the relationships between
microbiotaandcancer,host-geneeffects,clinicalfactorsanden-
vironmental exposures have not been previously investigated.
Elucidation of HNSCC-speciﬁc microbial subpopulations
could greatly improve our understanding of the genetic altera-
tionsthataremanifestationsofthebacterialpopulations.Identi-
ﬁed populations could also serve as effective targets for early
detection or prediction and would revolutionize HNSCC diag-
nosis and treatment. Thus, we sought to determine whether spe-
ciﬁc microbiomic proﬁles are associated with HNSCC in the
context of promoter hypermethylation of genes that were previ-
ously implicated in HNSCC and/or inﬂammation.
RESULTS
Microbiomic proﬁles and DNA methylation between
HNSCC and matched normal oral mucosa
We analyzed bacteria-speciﬁc 16S rRNA genes to examine
microbiomic proﬁles of 42 paired normal-tumor specimens
from HNSCC patients in the context of methylation of
MDR1 and three other genes that are known to be associated
with inﬂammation (IL8) or with HNSCC (RARB, TGFBII),
assessed by combined bisulﬁte restriction analysis (COBRA).
Overall, there was more promoter methylation in all four
genes in the tumors compared with the matched normal
tissue (P , 0.01) (Fig. 1). MDR1 shows the greatest difference
between normal and tumor samples, with 0/42 methylation
events in normal mucosa in comparison to 22/42 methylation
events in tumor mucosa (P , 10
29).
Microbiomic proﬁling revealed seven different phyla repre-
sented in the oropharyngeal tissues (Fig. 2). The relative quan-
tities of the bacterial subpopulations, most striking at the phyla
level, clearly differ between the HNSCC tumors and paired
normal mucosae. Comparison of bacterial subpopulations in
paired normal-tumor samples in thesameindividual reveals dif-
ferences between members of each pair, even by visual inspec-
tion. Taxonomic hierarchy of the bacterial subpopulations,
from phylum to genus, observed in the specimens is depicted
in Figure 3A. When viewed at the group level (all tumors
versusallmatchednormal),variationsindistributionthatdistin-
guishbetweentumorandnormalcanalsobeobserved(Fig.3B).
These distinctions remain signiﬁcant despite differences in dis-
tribution of microbial subpopulations among oropharyngeal
sites (Fig. 3C). Speciﬁcally, Enterobacteriaceae (family) and
Tenericutes (phylum) were formally identiﬁed by multivariate
analysis of variance (MANOVA) as signiﬁcantly different
(P , 0.001foreach)betweentumorandadjacenttissue(Fig.4).
By factor analysis, a statistical method used to describe
variability among observed variables (Supplementary Mater-
ial, Methods), we found that HPV status was not associated
with speciﬁc bacterial subpopulations in differentiating
HNSCC from normal tissue nor was it associated with
MDR1 methylation status (Supplementary Material, Fig. S1).
Signiﬁcant association among speciﬁc microbial
subpopulations, MDR1 methylation and regional nodal
status in HNSCC tumors
Multivariate analysis of covariance (MANCOVA) was applied
to clinically relevant variables and to methylation status of the
1558 Human Molecular Genetics, 2012, Vol. 21, No. 7four genes of interest (Supplementary Material, Table S1) to
determine whether any of these measures differentiate
normal oral mucosal epithelium from HNSCC in the context
of speciﬁc microbiomic proﬁles (Supplementary Material,
Tables S2 and S3). This test performs general linear modeling
for multiple responses that are also likely covariates.
MANCOVA veriﬁed signiﬁcant differences with regard to
all variables (P , 0.01). We proceeded to see which of the
variables have signiﬁcantly different means across the
groups. First, we found that hypermethylation of the promoters
of MDR1 (P , 10
29) and IL8 (P , 0.019) was signiﬁcant dis-
criminators of tumor compared with normal specimens, irre-
spective of microbiomic proﬁles. Secondly, this multivariate
analysis clearly shows that hypermethylation of MDR1 is asso-
ciated with speciﬁc microbial subﬂora, and these two factors
together are also able to differentiate HNSCC from normal
oral mucosa (Fig. 4). Speciﬁcally, MDR1 methylation in the
context of HNSCC (versus normal oral mucosa) was asso-
ciated with Enterobacteriaceae (family) and Tenericutes
(phylum). In contrast, IL8 methylation in HNSCC is not corre-
lated with speciﬁc microbial populations (Fig. 4).
General linear modeling with multiple responses also
showed that MDR1 methylation has a similar association
with clinical nodal stage (cN) in the context of microbial sub-
populations in differentiating HNSCC versus matched normal
oral epithelium (Supplementary Material, Fig. S1). Indeed,
MDR1 methylation associated with advanced regional nodal
metastases (any cN .1) in the context of two speciﬁc bacterial
subpopulations, Enterobacteriaceae and Tenericutes (Fig. 4).
Moreover, increased age-at-diagnosis, larger tumor size and
Figure 1. Scatter plot of methylation status of IL8, TGFBR2, MDR1 and RARB gene promoters. Each dot represents the presence of promoter hypermethylation
of that gene in that particular tumor sample compared with its corresponding normal oral mucosal tissue. There are 42 paired tumor and normal mucosa samples
analyzed for these four genes.
Figure 2. Microbial subpopulational content at the phylum level of HNSCC and matched normal mucosa. Each bar represents a sample, and the bars are split
showing the microbial content quantitatively of that sample at the phylum level. There are 42 matched HNSCC (top) and normal oral mucosal (bottom) samples
where a total of 7 microbial phyla identiﬁed.
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similar patterns in bacterial subpopulations (Fig. 4), although
RARB methylation alone does not differentiate normal from
tumor.
Association of speciﬁc microbiome with tobacco but not
alcohol exposure in HNSCC
MANOVA testing, which can determine whether the mean
of a variable differs signiﬁcantly among canonical vari-
ables—in this case, microbial populations—was used to in-
vestigate tobacco and alcohol exposure in relationship to
microbiomic proﬁles. Figure 5 depicts the ﬁrst two canonical
variables from this analysis, which are linear combinations
of the original variables, maximizing the separation
between bacterial subpopulations. Bacterial subpopulations
signiﬁcantly differentiated tobacco users from non-users
(P , 0.008) (Fig. 5A). No correlation to microbial proﬁles
was found in alcohol users (P ¼ 0.41) (Fig. 5B). An analysis
of patients who both smoke and drink alcohol compared with
the rest of the cohort did not return any signiﬁcant results
(P ¼ 0.17).
Among tobacco users compared with non-users, decreases
in Flavobacteria (class) and in Tenericutes (phylum) were
Figure 3. Microbiomic content of the paired normal and tumor samples. (A) Biological classiﬁcations of the bacteria are shown. The baseline is the kingdom
bacteria, and each level represents the next taxonomic rank (phylum, class, order, family, genus). (B) rRNA-based count of each microbial population in normal
and tumor samples are represented by boxplots. Separate circles represent the outliers. (C) Site-speciﬁc microbial classiﬁcations are shown. Distribution of
bacteria in HNSCC sites is indicated by columns of triangles to the right of the taxonomy tree, where the left triangle represents tumor samples and the
right represents the corresponding normal mucosa samples.
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cantly less frequent in smokers compared with non-smokers,
whereas Flavobacteria and its phylum Bacteroidetes were
slightly less frequent in smokers over non-smokers.
DISCUSSION
Despite research efforts in HNSCC, there has been little im-
provement in treatment efﬁcacy or effective early diagnosis
Figure 4. MANCOVA of bacterial subpopulations, DNA methylation status and clinical and exposure information in HNSCC and matched normal tissue. The
heat map depicts –log(P-values), i.e. orange and darker are signiﬁcant at least at the P , 0.05 level. The bacterial populations detected are listed on the x-axis,
and the models that are considered in the analysis are listed on the y-axis. Models with variables MDR1 methylation, RARB methylation, sex, age (dichotomized
at cut-off 62.5 years), clinical tumor stage (cT, dichotomized at stages 2 or more) and clinical nodal involvement (cN, dichotomized at 0 versus 1 or more). The
models that were not signiﬁcant (e.g. IL8) are not shown.
Figure 5. MANOVA correlates tobacco use with microbiome but not alcohol use. The plots depict MANOVA results. The two axes are the ﬁrst two canonical
variables from the analysis where these variables are calculated based on linear combinations of the mean-centered original values of the microbiome in the
samples analyzed. (A) The scatter plot of tobacco use canonical variables shows more separation between groups (P , 0.0036), whereas (B) alcohol use
scatter plot shows two clouds that have a larger overlap (P ¼ 0.41).
Human Molecular Genetics, 2012, Vol. 21, No. 7 1561of this disease, and a paradigmatic shift may be required to
make progress. When H. pylori in the stomach was linked
with gastric cancer, a new model of carcinogenesis and a
novel way to eradicate this cancer were introduced. With the
knowledge of the clinical epidemiologic association between
oral hygiene and HNSCC and that chronic inﬂammation asso-
ciated with persistent presence of abnormal bacteria can
induce DNA damage through aberrant de novo DNA methyla-
tion (11), we set out to determine speciﬁc microbiomic proﬁles
which associate with promoter hypermethylation of genes
relevant to HNSCC and/or to inﬂammation and clinico-
pathologic features. For our methylation analysis, we had the
option of analyzing a few well-rationalized candidate genes
or performing whole-genome methylation proﬁling. We pur-
posefully chose the former, based on with well-established
links to inﬂammation and/or HNSCC pathogenesis. Methy-
lome analysis would have almost certainly resulted in multiple
testing-based errors given the number of genes interrogated,
the number of microbial subpopulations assessed, and our
sample sizes. Thus, we carefully selected four genes: MDR1,
whose promoter methylation has been correlated with Helico-
bacter pylori infection (a precedent microbe) and gastric car-
cinogenesis (21); IL8, a well-characterized inﬂammatory
cytokine (16); RARB, which has frequent promoter hyper-
methylation in HNSCC (17); and TGFBR2, which is well
established in HNSCC, GI carcinogenesis and inﬂammation
(16,18,19).
Evidence of a link between microbiota and HNSCC
In this study, we have shown that certain microbial subpopu-
lations in HNSCC are strongly associated with MDR1 pro-
moter methylation, thus setting the stage for future
investigation for a potential mechanistic link to inﬂammation
and tumorigenesis. First, we have shown that there are
subtle regional differences in microbiomic composition
(Fig. 3). Despite this, we have also shown microbiomic pro-
ﬁles, particularly regarding Enterobacteriaceae (family) and
Tenericutes (phylum), differentiate HNSCC tumors from
their paired normal counterparts (Figs 2 and 3). Secondly,
we saw strong associations only between speciﬁc microbiomic
proﬁles and MDR1 methylation, but no correlations were
present for the other three genes tested. The presence of
MDR1 methylation can differentiate between HNSCC and
matched normal oral mucosa. Furthermore, MDR1 promoter
methylation was not observed in any of our normal samples.
Our observations hint that speciﬁc microbe-associated inﬂam-
mation could lead to MDR1 methylation, a causation chain
that has been observed in other diseases such as inﬂammatory
bowel disease and has been associated with more aggressive
disease states (21,22). In support of these ﬁndings, we see
the same microbial subpopulations that associate with MDR1
promoter methylation linked with worse nodal metastases.
While a small subset of samples had methylation in normal
samples and not in the tumor samples for the three genes other
than MDR1, these results might arise from preferential loss of
heterozygosity (LOH) events that favor the methylated allele
in these patient samples. Such a phenomenon was noted
while studying somatic methylation and LOH of the 3p
genes, including RASSF1A (Eng and Plass, unpublished data).
Despite their apparent use as early detection tools, hyper-
methylation events linked with bacteria-induced inﬂammation
have not been extensively studied for their clinical application.
Because development of early detection tools is drastically
needed to improve HNSCC treatment outcome, elucidation
of speciﬁc microbial consortia that could serve as effective
targets for early detection or prediction would potentially
revolutionize HNSCC diagnosis and treatment.
Microbiota-associated methylation is independent
of HPV status
HPVinfection isastrongriskfactorforHNSCC (23)regardless
of other factors, such as tobacco or alcohol use. Our ﬁndings
suggest that speciﬁc subtypes of microbiota associate with the
methylationofspeciﬁcgenesaswellastoHNSCC,independent
of HPV status. While HPV+ HNSCC appears to favor certain
sites, e.g. tonsils, we have controlled for this by repeating our
analysis with site-matched HPV+ and HPV2 patient samples
(data not shown). Using this type of site-matched analysis,
HPV status remains not statistically signiﬁcant in correlating
with either speciﬁc microbiomes or methylation of the speciﬁc
genes examined. In partial support of the latter, we previously
studied tonsillar carcinomas and showed that a speciﬁc set of
genes known to be somatically hypermethylated in HNSCC
associated directly with alcohol and tobacco exposure, but not
withHPVstatus(24).Intriguingly,theindependenceofourﬁnd-
ings from HPV status reinforces the commonly held notion that
HPV+ HNSCC has a different etiologic mechanism and bio-
logic behavior than tobacco- and alcohol-related HNSCC and
suggests that methylation of inﬂammatory genes is not neces-
sary for HPV+ carcinogenesis.
Concurrent analysis of methylation status of speciﬁc genes
add great value to this analysis in linking and identifying a
likely candidate for a carcinogenic mechanism, namely that ab-
errant methylation could possibly be triggered through inﬂam-
mation caused by microbial populations at the at-risk oral site.
Thisassociationcouldleadtobetterunderstandingofthepatho-
genesis of HNSCC, suggesting value in future direct
cause-effect mechanistic studies, and if so proven, a role for
novel treatment strategies in HNSCC such as demethylating
agents and probiotic adjuncts (25), in particular for
HPV-negativediseasewhichcontinuestocarryapooroutcome.
Interaction of key risk factors of HNSCC with microbiota
We have also identiﬁed that speciﬁc microbes are observed in
the context of tobacco use but not with alcohol exposure in
HNSCC. Tenericutes (phylum) populations were signiﬁcantly
lower in smokers and Flavobacteria class and its overarching
phylum Bacteroidetes were slightly lower in smokers over
non-smokers. The decrement in these speciﬁc subpopulations
may be due to morphological differences of these bacteria
(e.g. lack of a rigid cell wall). Our correlative observations,
albeit preliminary, could suggest that the carcinogenic path-
ways of two established HNSCC risk factors, tobacco and
alcohol, may differ by modulating the oral microbiome.
While tobacco exposure might favor a bacterial subpopulation-
associated pathway leading perhaps to inﬂammation, alcohol
exposure may be agnostic to bacterial subpopulations or
1562 Human Molecular Genetics, 2012, Vol. 21, No. 7induce carcinogenesis independent of speciﬁc microbial sub-
populations. We have presented smoking and alcohol exposure
variables in a straightforward manner in our analysis. Future
studies including more complex features of these key risk
factors would give more insight about their relation to
HNSCC.
In conclusion, we have shown that epigenetic modiﬁcations
in HNSCC-associated genes and clinico-pathologic features of
patients associate with certain bacteria as manifested by spe-
ciﬁc microbiomic sub-proﬁles. We suspect that our
microbiome-association with HNSCC can be generalizable
to other cancers, especially those at sites where normal micro-
bial ﬂora resides, such as those of the colon and skin. We also
suspect that oral and other microbiomes may also inﬂuence
risk of diseases other than neoplasia (e.g. heart disease),
where an epidemiologic link with dental hygiene is known
to exist. As our knowledge of host–microbiome relationship
increase, we will be able to better understand the relative
role of the microbiome to health status and interventional
outcomes.
MATERIALS AND METHODS
Study population
HNSCC frozen tissue and parafﬁn-embedded samples of
paired tumor and normal oral mucosa and demographic and
clinical data were collected from 42 prospectively accrued
consecutive HNSCC patients (Table 1). Clinical and demo-
graphic information such as smoking and alcohol exposure
status, clinical tumor stage such as tumor size (cT) and region-
al nodal involvement (cN), tumor site, HPV status (HPV16
and 18 status, see below for details), age, sex and metastatic
status were also collected from these specimen donors (see
Supplementary Material, Tables S1–S3 for full tables). The
research protocol has been approved by the Cleveland Clinic
Human Subjects’ Protection Committee.
DNA extraction
Fresh frozen was utilized for extraction of human genomic
DNA using standard methods (see Supplementary Material,
Methods).
Microbiomic analyses
DNA ampliﬁcation and sequencing of rRNA genes. rRNA gene
fragments were ampliﬁed with a set of primers targeting vari-
able regions 1–4 of the prokaryotic 16S rRNA gene. Two
microliters of DNA template was used from each sample, as
well as HotStarTaq DNA Polymerase Kit (Qiagen) in a 7900
HT Fast Real-Time polymerase chain reaction (PCR) System
(Applied Biosystems, Foster City, CA, USA). PCR was per-
formed under the following conditions: an initial denaturation
for 10 min at 958C; followed by 35 cycles for 30 s at 948C,
40 s at 568C and 1 min 20 s at 728C; lastly, the PCR was com-
pleted with 10 min at 728C. After PCR, DNA gel extraction
was performed with a 1% agarose gel using the Qiagen gel ex-
traction kit and protocol. The DNA products were then TOPO
TA cloned into pSC-A vector using the StrataClone PCR
cloning protocol (Qiagen). Each sample was spread onto an
ampicillin LB agar plate and grown at 378C overnight. Ap-
proximately 96 bacterial colonies were randomly selected
from a given plate and subjected to PCR ampliﬁcation as
described above using M13 primers. Gel electrophoresis on
1% agarose using 5 ml of the total 10 ml reaction was used to
conﬁrm the presence of the vector insert in each sample. SAP
treatment was performed with the addition of 1 mlS A Pa n d
0.25 ml of Exo1 enzyme to each PCR sample; afterwards, the
samples were incubated at 378C for 20 min followed by 828C
for 15 min. Lastly, M13 reverse primer was added and the
samples were sent for Sanger sequencing. Charts displaying
Table 1. Clinical and histopathological characteristics of the HNSCC patients
analyzed
Number of patients 42
Median age (years; range) 62 (32–85)
Gender, n (%)
Male 26 (62)
Female 16 (38)
Histological differentiation, n (%)
Well 4 (10)
Well-mod 2 (5)
Mod 18 (43)
Mod-poor 11 (26)
Poor 5 (12)
NOS/other 2 (5)
Tumor site, n (%)
Tongue 9 (21)
Larynx 12 (29)
Tonsil 8 (19)
Floor of mouth 3 (7)
Oral cavity 4 (10)
Hypopharynx 2 (5)
Other 4 (10)
Clinical T stage, n (%)
0 3 (7)
1 3 (7)
2 10 (24)
3 10 (24)
4 16 (38)
Clinical N stage, n (%)
0 21 (50)
1 8 (19)
2 11 (26)
3 2 (5)
Prior surgery, n (%)
No 7 (17)
Yes 35 (83)
Prior XRT, n (%)
No 27 (64)
Yes 15 (36)
Prior chemotherapy, n (%)
No 33 (79)
Yes 9 (21)
Recurrence, n (%)
No 27 (64)
Yes 15 (36)
Smoker, n (%)
No 7 (17)
Yes 35 (83)
Alcohol use, n (%)
No 18 (43)
Yes 24 (57)
HPV+, n (%)
No 35 (83)
Yes 7 (17)
Human Molecular Genetics, 2012, Vol. 21, No. 7 1563abundance of taxonomic groups (26) show that a ﬁnal yield of
 50 and 90 sequences show equivalent proportions of micro-
bial subpopulations (Supplementary Material, Fig. S2).
Taxonomic assignment of rRNA sequences. To identify the
bacteria represented by the sequences, we utilized a commonly
used existing pipeline. Ribosomal Database Project-Release
10 was utilized for aligning and classifying the sequences to
maximize the number of sequences correctly classiﬁed.
Sanger sequenced samples (described above) were assigned
to bacterial taxonomies by The Ribosomal Database Project
(RDP) Classiﬁer (27), a naı ¨ve Bayesian classiﬁer and a
count of bacterial populations at different levels was acquired
(Fig. 3 and Supplementary Material, Table S1).
Detection of promoter methylation
Bisulﬁte treatment of DNA. 1.0 mg DNA was obtained from
each sample and placed in a volume of 50 ml. Five microliters
of fresh 3 M NaOH was then added and the samples were incu-
bated at 378C for 25–30 min. Afterwards, 30 ml1 0m M hydro-
quinone and 520 ml3M sodium bisulﬁte were added to each
sample and the samples were incubated at 508C for 16 h.
The DNA was then isolated using the Qiaquick gel extraction
kit according to their protocol (Qiagen) and 5 ml fresh 3 M
NaOH was added to each sample before incubation at room
temperature for 20 min. Finally, 20 ml3 M NaOAc (pH 5)
was added and the DNA was puriﬁed again using the Qiaquick
gel extraction kit, eluting with 30 ml elution buffer (Qiagen).
Combined bisulﬁte restriction analysis (COBRA). Upstream
regulatory sequences of MDR1 and three other selected
genes that are associated with inﬂammation (IL8) or HNSCC
(RARB, TGFBII) were ampliﬁed from bisulﬁte converted
DNA using PCR primers speciﬁc for bisulﬁte-treated DNA
(sequences available upon request). PCR products were
digested with BstUI, a restriction enzyme that cuts at an
intact CpG (NEB; Ipswich, MA, USA). Next, the products
were run out on 8% polyacrylamide gel electrophoresis gels.
As bisulﬁte treatment converts only unmethylated cytosine
residues to thymidine, digested products on the COBRA gel
indicate methylation, while undigested bands represent
unmethylated DNA. Tumor samples were scored as methy-
lated if they evidenced methylation in the form of digested
bands that were not seen in the COBRAs of their ‘adjacent
normal’ counterparts (28).
HPV status detection by PCR-based assays
HPV16 and HPV18 ampliﬁcations were performed using Hot-
Start Taq (Qiagen) according to the manufacturer’s instruc-
tions. Brieﬂy, 10 ml HotStart was combined with 1 mlo f
forward primer (10 pM), 1 ml reverse primer (10 pM), 7 ml
water and 1 ml HNSCC patient DNA. The PCR conditions
were as follows: 958C for 10 min; 35 cycles of 958C for
30 s, 568C for 30 s and 728C for 30 s; followed by 728C for
10 min. PCR products were analyzed on an 8% polyacryl-
amide gel. Primer sequences are available upon request.
Statistical analyses
MANOVA was used to test hypotheses of whether dependent
variables are affected by the difference in observed microbial
populations, e.g. tumor versus non-tumor. Matlab (Math-
works, Natick, MA, USA) anova1 and manova1 functions
were used. The plots to depict MANOVA statistical results
were also generated in Matlab utilizing the canonical variable
from MANOVA results using various plotting functions. The
Matlab package ffmanova was used to perform general
linear modeling with multiple responses (MANCOVA). An
overall P-value for each model term is calculated by the
50–50 MANOVA method, which handles collinear responses.
In these analyses, we assumed that the microbial data follow a
normal distribution, with some outliers (Fig. 3 and Supple-
mentary Material, Fig. S3). This library uses rotation testing
to compute adjusted single response P-values according to
family-wise error rates and false discovery rates. The results
were plotted for further investigation.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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